The role of ovarian reserve markers in prediction of clinical pregnancy

References

• Aboulghar M, Saber W, Amin Y, Aboulghar MM, Serour G, Mansour R. 2014. Impact of antimüllerian hormone assays on the outcomes of in vitro fertilization: a prospective controlled study. Fertility and Sterility 101:134–137.
   PubMed Web of Science ®Google Scholar
• Biljan MM, Buckett WM, Dean N, Phillips SJ, Tan SL. 2000. The outcome of ıvf-embryo transfer treatment in patients who develop three follicles or less. Human Reproduction 15:2140–2144.
   PubMed Web of Science ®Google Scholar
• Broer SL, Mol BW, Hendriks D, Broekmans FJ. 2009. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count . Fertility and Sterility 91:705–714.
   PubMed Web of Science ®Google Scholar
• Choi MH, Yoo JH, Kim HO. 2011. Serum anti-müllerian hormone levels as a predictor of the ovarian response and IVF outcomes. Clinical and Experimental Reproductive Medicine 38:153–158.
   PubMedGoogle Scholar
• Cupisti S, Dittrich R, Mueller A. 2007. Correlations between anti-müllerian hormone, inhibin b, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes . European Journal of Medical Research 12:604–608.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. 2002. Anti-müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076–1084.
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Ben-Chetrit A, Spitz IM. 2005. Dynamic assays of inhibin b, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human Reproduction 20:3178–3183.
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BC. 2011. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction 26:1616–1624.
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Velde ER, Looman CW, Bancsi LF, Broekmans FJ. 2008. Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool. Reproductive Biomedicine Online 17:727–736.
   PubMed Web of Science ®Google Scholar
• Inge GB, Brinsden PR, Elder KT. 2005. Oocyte number per live birth in ıvf: were steptoe and edwards less wasteful? Human Reproduction 20:588–592.
   PubMed Web of Science ®Google Scholar
• Lin WQ, Yao LN, Zhang DX, Zhang W, Yang XJ, Yu R. 2013. The predictive value of anti-müllerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (ıvf-et). Journal of Assisted Reproduction and Genetics 30:649–655.
   PubMed Web of Science ®Google Scholar
• Lukaszuk K, Kunicki M, Liss J, Bednarowska A, Jakiel G. 2014. Probability of live birth in women with extremely low anti-müllerian hormone concentrations. Reproductive Biomedicine Online 28:64–69.
   PubMed Web of Science ®Google Scholar
• Majumder K, Gelbaya TA, Laing I, Nardo LG. 2010. The use of anti-müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. European Journal of Obstetrics, Gynecology and Reproductive Biology 150:166–170.
   PubMed Web of Science ®Google Scholar
• Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. 2005. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? British Journal of Obstetrics and Gynaecology 112:1384–1390.
   Web of Science ®Google Scholar
• Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. 2011. Serum anti-müllerian hormone and antral follicle count as predictive markers of ohss in art cycles. Journal of Assisted Reproduction and Genetics 28:1197–1203.
   PubMed Web of Science ®Google Scholar
• Saldeen P, Källen K, Sundström P. 2007. The probability of successful IVF outcome after poor ovarian response. ActaObstetricia et Gynecologica Scandinavica 86:457–461.
   PubMed Web of Science ®Google Scholar
• Sahmay S, Demirayak G, Guralp O. 2012. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in ıvf/ıcsı cycles. Journal of Assisted Reproduction and Genetics 29:589–595.
   PubMed Web of Science ®Google Scholar
• Sahmay S, Guralp O, Aydogan B, Cepni I, Oral E, Irez T. 2013. Anti-müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients. Gynecological Endocrinology 29:440–443.
   PubMed Web of Science ®Google Scholar
• Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. 2007. Stable serum levels of anti-müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Human Reproduction 22:1837–1840.
   PubMed Web of Science ®Google Scholar
• Veeck LL. 1999. Preembryo grading and degree of cytoplasmic fragmentation. An atlas of human gametes and conceptuses: an illustrated reference for assisted reproductive technology. New York (NY): Parthenon Publishing. p. 46–51.
   Google Scholar
• Vural B, Cakiroglu Y, Vural F, Filiz S. 2014. Hormonal and functional biomarkers in ovarian response. Archives of Gynecology and Obstetrics 289:1355–1361.
   PubMed Web of Science ®Google Scholar
• Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA. 2008. Anti-müllerian hormone and inhibin b as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility 90:2203–2210.
   PubMed Web of Science ®Google Scholar
• Weghofer A, Kim A, Barad DH, Gleicher N. 2012. Follicle stimulating hormone and anti-müllerian hormone peroocyte in predicting in vitro fertilization pregnancy in high responders: a cohortstudy. PLoS One 7:e34290.
   PubMed Web of Science ®Google Scholar
• Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. 2009. Serum anti-müllerian hormone predicts ovarian response and cycle outcome in IVF patients. Journal of Assisted Reproduction and Genetics 26:383–389.
   PubMed Web of Science ®Google Scholar
• Yoo JH, Cha SH, Park CW. 2011. Serum anti-Müllerian hormone is a better predictor of ovarian response than fsh and age in ıvf patients with endometriosis. Clinical and Experimental Reproductive Medicine 38:222–227.
   PubMedGoogle Scholar